NCT02773407View on ClinicalTrials.gov

Nepal Undifferentiated Febrile Illness Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

May 23, 2016

Primary Completion Date

August 4, 2019

Study Completion Date

August 4, 2019

Conditions
Undifferentiated Febrile Illness
Interventions
DRUG

Azithromycin

DRUG

Co-trimoxazole

Trial Locations (2)

Unknown

Nepal Civil Service Hospital, Kathmandu

Patan Hospital, Kathmandu

All Listed Sponsors
collaborator

University of Oxford

OTHER

collaborator

Wellcome Trust

OTHER

lead

Oxford University Clinical Research Unit, Vietnam

OTHER

NCT02773407 - Nepal Undifferentiated Febrile Illness Trial | Biotech Hunter | Biotech Hunter